Publications by authors named "Celia Sequera"

Claim this Profile
E
Establishment of a mouse hepatocellular carcinoma tumoroid panel recapitulating inter- and intra- heterogeneity for disease modelling and combinatorial drug discovery.
Margherita Grattarola, Nicolas Pons, Floriane Cannet, Müge Kaya, Abdessamad El Kaoutari, Celia Sequera

Cell Commun Signal· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.
Celia Sequera, Margherita Grattarola, Floriane Cannet, Aurélie Dobric, Paula Michea Veloso

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response.
Cristina Baquero, Minerva Iniesta-González, Nerea Palao, Cristina Fernández-Infante, Mateo Cueto-Remacha, Celia Sequera

J Pathol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracing specificity of immune landscape remodeling associated with distinct anticancer treatments.
Floriane Cannet, Célia Sequera, Paula Michea Veloso, Abdessamad El Kaoutari, Melissa Methia

iScience· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.
Celia Sequera, Margherita Grattarola, Agnes Holczbauer, Rosanna Dono, Stefania Pizzimenti

Cell Death Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process.
Nerea Palao, Celia Sequera, Ángel M Cuesta, Cristina Baquero, Paloma Bragado

Int J Biol Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling.
Patricia Rada, Fabienne Lamballe, Elena Carceller-López, Ana B Hitos, Celia Sequera

Cells· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two is better than one: combinatorial receptor targeting enhances hepatocellular carcinoma (HCC) therapeutic response.
Celia Sequera, Flavio Maina

Hepatobiliary Surg Nutr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.
Maria Arechederra, Sehrish K Bazai, Ahmed Abdouni, Celia Sequera, Timothy J Mead

J Hepatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.
Sara Manzano, Alvaro Gutierrez-Uzquiza, Paloma Bragado, Celia Sequera, Óscar Herranz

Cell Death Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation.
Celia Sequera, Paloma Bragado, Sara Manzano, Maria Arechederra, Sylvie Richelme

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TWEAK promotes migration and invasion in MEFs through a mechanism dependent on ERKs activation and Fibulin 3 down-regulation.
Celia Sequera, Ana Vázquez-Carballo, María Arechederra, Sonia Fernández-Veledo, Almudena Porras

J Cell Physiol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma.
Celia Sequera, Sara Manzano, Carmen Guerrero, Almudena Porras

Hepat Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis.
Víctor Martín-Granado, Sara Ortiz-Rivero, Rita Carmona, Sara Gutiérrez-Herrero, Mario Barrera, Celia Sequera

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms.
Neibla Priego, María Arechederra, Celia Sequera, Paloma Bragado, Ana Vázquez-Carballo

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: role in migration and invasion.
María Arechederra, Neibla Priego, Ana Vázquez-Carballo, Celia Sequera, Álvaro Gutiérrez-Uzquiza

J Biol Chem· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis